Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOONTALK MEDIA LIMITED (SEJ)

  • Business News
  • July 31, 2026, 11:06 UTC
  • 1
  • 1 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: DISCLOSURE IN INTEREST OF DIRECTOR - WEE KENG NEO LYNDA

Market reaction Comment Full text

OCUGEN, INC. (OCGN)

  • Business News
  • July 31, 2026, 11:02 UTC
  • 1
  • 1 comments

Ocugen to Participate in Upcoming August Investor Conferences

Market reaction Comment Full text

PRECISION BIOSCIENCES INC (DTIL)

  • Business News
  • July 31, 2026, 11:01 UTC
  • 1
  • 1 comments

Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026

Market reaction Comment Full text

GCL GLOBAL HOLDINGS LTD (GCL)

  • Business News
  • July 31, 2026, 11:01 UTC
  • 1
  • 1 comments

GCL Announces Fiscal Year 2026 Financial Results

Market reaction Comment Full text

PRICE T ROWE GROUP INC (TROW)

  • Business News
  • July 31, 2026, 11:00 UTC
  • 1
  • 1 comments

T. ROWE PRICE GROUP REPORTS SECOND QUARTER 2026 RESULTS

Market reaction Comment Full text

GLOBAL PHARMATECH, INC. (OTCM)

  • Business News
  • July 31, 2026, 11:00 UTC
  • 1
  • 1 comments

American Tungsten Corp. Begins Trading on OTCQX Best Market

Market reaction Comment Full text

TENAX THERAPEUTICS, INC. (TENX)

  • Business News
  • July 31, 2026, 11:00 UTC
  • 1
  • 1 comments

Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Market reaction Comment Full text

WEREWOLF THERAPEUTICS, INC. (HOWL)

  • Business News
  • July 31, 2026, 11:00 UTC
  • 1
  • 1 comments

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

Market reaction Comment Full text

INMUNE BIO, INC. (INMB)

  • Business News
  • July 31, 2026, 11:00 UTC
  • 1
  • 1 comments

INmune Bio Receives R&D Rebates of Approximately $4.6 Million

Market reaction Comment Full text

ENBRIDGE INC (ENB)

  • Business News
  • July 31, 2026, 11:00 UTC
  • 1
  • 1 comments

Enbridge Reports Strong Second Quarter Results, Reaffirms 2026 Guidance and Grows Secured Backlog to $41B

Market reaction Comment Full text
  • Previous
  • 120
  • 121
  • 122
  • 123
  • 124
  • Next

Search

News categories

  • Technical Exchange News(14063)
  • Event(6229)
  • SEC News(358603)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(217525)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin